Gastroenterology Clinical Trials

REMODEL-CD

Condition: Chron's Disease (CD)

Type of Research: Multi-Site, open-label

Principal Investigator: Rana Ammoury, MD

Study Specifications: Chron’s disease (CD) is an illness that brings GI inflammation and other unwanted GI symptoms. There is an unmet need for a pediatric intervention to treat CD. This study will test whether precision infliximab dosing is effective in achieving remission compared to patients receiving conventional infliximab dosing.

DEVELOP

Conditions: Inflammatory Bowel Diseases; Crohn’s Disease, Ulcerative Colitis, Indeterminate Colitis

Type of Research: Observational

Study Specifications: REMICADE® (infliximab) has been approved for the treatment of children and adults with Crohn’s disease (CD) and adults with ulcerative colitis (US). The DEVELOP registry aims to provide additional information on pediatric IBD following the approval of Remicade indication for pediatric CD in the US and EU. 

Email:CRU@chkd.org
Phone: (757) 668-5416